CD47 and cancer: We initially hypothesized that CD47 overexpressed within infected cancer cells could prolong viral replication by limiting the rapid phagocytosis of virus-infected tumor cells, thereby delaying the production of neutralizing antibodies against the virus and ensuring increased production of other therapeutic transgenes.